Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis
- 1 September 1993
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 13 (5) , 529-568
- https://doi.org/10.1002/med.2610130503
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin againstToxoplasma gondiiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous systemEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Treatment of acute toxoplasmosis with oral clindamycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatmentThe Journal of Pediatrics, 1989
- Toxoplasmose-Diagnostik in der SchwangerschaftGeburtshilfe und Frauenheilkunde, 1989
- In vivo and in vitro activity of roxithromycin againstToxoplasma gondii in miceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Oxygen-Dependent Microbial Killing by PhagocytesNew England Journal of Medicine, 1978
- Oxygen-Dependent Microbial Killing by PhagocytesNew England Journal of Medicine, 1978
- TOXOPLASMIC ENCEPHALITIS IN CHILDRENJAMA, 1941